However, CRISPR with an adeno-associated virus (AAV) delivery system allows for the simultaneous mutation of five tumor suppressors (TP53, PTEN, Rb1, Stk11, and RnaseL), resulting in the creation of a rapid, invasive, and androgen-independent tumor mouse model. The gene discussed is RB1; the disease is neoplasm.